TM6SF2 and metabolic dysfunction-associated steatohepatitis: The TM6SF2 variant rs58542926 known as p.E167K was associated with steatosis and fibrosis in NASH patients, independently of diabetes mellitus (DM), obesity or PNPLA3 variant [33,34].